Building 302, our small molecule design and development facility, is now open in our hometown of #Indianapolis. This #research and development center features laboratories that facilitate multi-disciplinary collaboration, where researchers utilize advanced technologies to accelerate the development of new medicines across our five therapeutic areas – diabetes, oncology, neurodegeneration, immunology and pain. #WeAreLilly #BeALillyScientist 🔬